These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7890970)

  • 1. Lymphocytes at tumor margins in patients with head and neck cancer. Relationship with tumor size, human lymphocyte antigen molecules, and metastasis.
    Slootweg PJ; de Pagter M; de Weger RA; de Wilde PC
    Int J Oral Maxillofac Surg; 1994 Oct; 23(5):286-9. PubMed ID: 7890970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
    Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
    Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.
    Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E
    Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the changes of antitumor immune response during lymph node metastasis in head and neck squamous cell carcinoma.
    Kumagai K; Hamada Y; Gotoh A; Kobayashi H; Kawaguchi K; Horie A; Yamada H; Suzuki S; Suzuki R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Sep; 110(3):341-50. PubMed ID: 20598595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of adenosine A2A receptor enhances CD8
    Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma.
    Sheu BC; Hsu SM; Ho HN; Lin RH; Torng PL; Huang SC
    Cancer; 1999 Oct; 86(8):1537-43. PubMed ID: 10526283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA traits linked to development of head and neck squamous cell carcinoma affect the progression-free survival of patients.
    Wichmann G; Herchenhahn C; Boehm A; Mozet C; Hofer M; Fischer M; Kolb M; Dietz A
    Oral Oncol; 2017 Jun; 69():115-127. PubMed ID: 28559015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
    Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
    Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
    APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
    BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phenotypic changes in tumour infiltrating lymphocytes and tumour cells following intra-arterial infusion of interleukin-2 in patients with squamous cell carcinoma.
    Salter J; Maclennan KA; Moore J; Dadian G; Riches PG; Gore ME
    J Pathol; 1995 Jun; 176(2):167-73. PubMed ID: 7636627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.
    Poropatich K; Hernandez D; Fontanarosa J; Brown K; Woloschak G; Paintal A; Raparia K; Samant S
    J Oral Pathol Med; 2017 Nov; 46(10):972-978. PubMed ID: 28632936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers.
    Uppaluri R; Dunn GP; Lewis JS
    Cancer Immun; 2008 Dec; 8():16. PubMed ID: 19053167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infiltrating CD57+ inflammatory cells in head and neck squamous cell carcinoma: clinicopathological analysis and prognostic significance.
    Fraga CA; de Oliveira MV; Domingos PL; Botelho AC; Guimarães AL; Teixeira-Carvalho A; Correa-Oliveira R; De Paula AM
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):285-90. PubMed ID: 22505010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-structural determinants of immunogenicity and the B cell co-receptors, CD19, CD21, and CD22.
    Fearon DT
    Adv Exp Med Biol; 1998; 452():181-4. PubMed ID: 9889972
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
    Nguyen N; Bellile E; Thomas D; McHugh J; Rozek L; Virani S; Peterson L; Carey TE; Walline H; Moyer J; Spector M; Perim D; Prince M; McLean S; Bradford CR; Taylor JM; Wolf GT;
    Head Neck; 2016 Jul; 38(7):1074-84. PubMed ID: 26879675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA molecule expression in cutaneous squamous cell carcinomas: an immunopathological study and clinical-immunohistopathological correlations.
    García-Plata D; Mozos E; Carrasco L; Solana R
    Histol Histopathol; 1993 Apr; 8(2):219-26. PubMed ID: 7683937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of B cell antigen receptor signaling by the Lyn/CD22/SHP1 pathway.
    Cornall RJ; Goodnow CC; Cyster JG
    Curr Top Microbiol Immunol; 1999; 244():57-68. PubMed ID: 10453649
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.
    Engel P; Wagner N; Miller AS; Tedder TF
    J Exp Med; 1995 Apr; 181(4):1581-6. PubMed ID: 7535343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.